Steris Applied Sterilization Technologies

Steris Applied Sterilization Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

STERIS AST operates as an indispensable, mission-critical service provider within the global healthcare supply chain, enabling medical device and pharmaceutical manufacturers to bring safe products to market. Its core strategy is built on a technology-agnostic portfolio—spanning radiation (gamma, E-beam, X-ray) and gas (EO, VHP, steam) modalities—combined with integrated testing and equipment services. This approach, supported by a vast global network and deep regulatory expertise, mitigates client supply chain risk and positions the company to capitalize on the growing outsourcing trend. Recent achievements, such as facility expansions in China and multiple OSHA VPP Star certifications, underscore its commitment to operational excellence, safety, and capacity growth.

Medical DevicesDiagnostics

Technology Platform

A technology-neutral, integrated suite of contract sterilization services encompassing radiation (gamma, electron beam, X-ray), gas (ethylene oxide, VHP), and steam modalities, supported by laboratory testing, equipment, dosimetry, and technical consulting.

Opportunities

The company is poised to benefit from the accelerating outsourcing trend in medtech, regulatory complexities favoring experts, and supply chain shifts driven by environmental scrutiny of legacy sterilization methods.
Its global, multi-technology platform is the ideal solution for innovative and multinational device manufacturers.

Risk Factors

Key risks include regulatory changes impacting specific sterilization technologies (e.g., ethylene oxide), operational/safety incidents at facilities, geopolitical or supply chain disruptions to its global network, and competitive pricing pressure.

Competitive Landscape

Competes against other large contract sterilization organizations (CSOs) and regional specialists. Its primary advantages are technology neutrality, global scale with over 60 facilities, an integrated service model, and the financial backing of parent STERIS plc.